The search found 3761 results.
Whitepaper
The DEA requires all practitioners who will be prescribing controlled substances electronically to undergo identity proofing, even if they have already been authorized to prescribe controlled substances using paper. This whitepaper outlines both individual and institutional identity proofing as well as the logical access control requirements necessary for a successful EPCS initiative.
News
Two bills in U.S. Congress this year are expected to boost e-prescriptions. This article explains the complexities that makes it so hard to implement electronic prescribing for controlled substances (EPCS), summarizes the intended impacts of the bills, and introduces Imprivata digital identity technology, which has been used in health care for such purposes for many years. To read the full article, visit www.healthcareittoday.com.
Datasheet
Electronic Prescribing of Controlled Substances (EPCS) can help tackle one of the most serious epidemics in the US today: prescription drug abuse. Twice as many deaths result from prescription drug overdose than from cocaine and heroin overdoses combined. In 2010, with almost 50 percent of all substance abuse deaths related to prescription drug overdose, the DEA responded by finalizing a rule allowing electronic prescribing of controlled substances (EPCS).